Jazz Pharmaceuticals Company information

Edit
Date
Employees
2,213 people
Ownership
Market cap
$6.8b
Net debt
$503m
Firm valuation
€6.6b (Public information from 2020)
USD20162017201820192020E2021E2022E
Revenues-1.6b1.9b2.2b2.3b2.5b2.7b
% growth--17 %14 %6 %8 %8 %
EBITDA-908m1.0b1.1b976m1.2b-
% EBITDA margin-56 %55 %52 %43 %50 %-
Profit-488m447m523m275m603m-
% profit margin-30 %24 %24 %12 %24 %-
EV / Revenue--4.6x4.4x3.2x2.8x2.3x
EV / EBITDA--8.4x8.4x7.5x5.5x4.3x
  • Edit
DateInvestorsAmountRound
N/A$7.1mSERIES A
$250mSERIES B
N/A$108mIPO
$7mPOST IPO EQUITY
N/A$120mPOST IPO DEBT
Total FundingFunding not available

Recent News about Jazz Pharmaceuticals

Edit
LocationEdit
United States, Palo Alto

Investments by Jazz Pharmaceuticals

Edit
Are you an employee or an investor of this company?
Add your profile